Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group. Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years

NCT Number	NCT03390894
Lead Sponsor	Spanish Breast Cancer Research Group Collaborators: AECC_Asociación Española contra el Cáncer
Conditions	Invasive Breast Cancer Early Stages
Enrollment	8,000 participants
Start Date	2018-01-18
Primary Completion	2047-01 (estimated)
Study Completion	2048-01 (estimated)
Updated on ClinicalTrials.gov	2025-05-14